EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Molecular Biomarkers for Predicting Treatment Response in Psoriatic Arthritis

Andre Lucas Ribeiro, Anne Barton, Jochen M Schwenk, Heidi Bertheussen, Maarten de Wit, Carl Goodyear, Stefan Siebert, Stephen R Pennington, Oliver FitzGerald

Rheumatic Disease Clinics of North America · 2025-08 · 51 (3) · e1-e15

DOI: 10.1016/j.rdc.2026.02.012 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Rheumatic Disease Clinics of North America, 2025-08. Verfasst von Andre Lucas Ribeiro und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hospital de Clínicas de Porto Alegre, 50 Prof. Duplan Street, Unit 609, Porto Alegre 90420-030, Brazil. Hauptthemen laut MEDLINE: Arthritis, Psoriatic, Biomarkers, Antirheumatic Agents. Die Arbeit nennt 69 Literaturangaben. Gefördert von: UCB, Teijin Pharma, GlaxoSmithKline Biologicals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Predicting treatment response is a key unmet need for people with psoriatic disease. In this article, the importance of personalized medicine is emphasized and molecular biomarker concepts are discussed. The literature related to biomarkers of treatment response in psoriatic disease is reviewed in detail. Finally, the limitations of current candidate biomarkers, emerging biomarkers, and future directions and challenges in biomarker research are highlighted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, PsoriaticBiomarkersAntirheumatic AgentsHumansTreatment OutcomePrecision Medicine

Stichwörter der Autor:innen

BiomarkersPsoriatic diseaseTreatment response

Substanzen

BiomarkersAntirheumatic Agents

Autor:innen und Institutionen

  • Hospital de Clínicas de Porto Alegre, 50 Prof. Duplan Street, Unit 609, Porto Alegre 90420-030, Brazil.
  • Division of Musculoskeletal and Dermatological Sciences, Centre for Genetics and Genomics Versus Arthritis, School of Biological Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester Aca…
  • Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Solna 171 65, Sweden.
  • Patient Research Partner (PRP), GRAPPA-EU, Norway.
  • Patient Research Partner (PRP), EULAR, Netherlands.
  • School of Infection and Immunity, University of Glasgow, 120 University Place, Glasgow G12 8TA, UK.

Förderung

  • UCB
  • Teijin Pharma
  • GlaxoSmithKline Biologicals

Zitieren

APA

Ribeiro, A. L., Barton, A., Schwenk, J. M., Bertheussen, H., de Wit, M., Goodyear, C., Siebert, S., Pennington, S. R., & FitzGerald, O. (2025). Molecular Biomarkers for Predicting Treatment Response in Psoriatic Arthritis. Rheumatic Disease Clinics of North America, 51(3), e1-e15. https://doi.org/10.1016/j.rdc.2026.02.012

Vancouver

Ribeiro AL, Barton A, Schwenk JM, Bertheussen H, de Wit M, Goodyear C, et al. Molecular Biomarkers for Predicting Treatment Response in Psoriatic Arthritis. Rheumatic Disease Clinics of North America. 2025;51(3):e1-e15. doi:10.1016/j.rdc.2026.02.012

BibTeX
@article{Ribeiro2025,
  author = {Ribeiro, Andre Lucas and Barton, Anne and Schwenk, Jochen M and Bertheussen, Heidi and de Wit, Maarten and Goodyear, Carl and Siebert, Stefan and Pennington, Stephen R and FitzGerald, Oliver},
  title = {Molecular Biomarkers for Predicting Treatment Response in Psoriatic Arthritis},
  journal = {Rheumatic Disease Clinics of North America},
  year = {2025},
  volume = {51},
  number = {3},
  pages = {e1--e15},
  doi = {10.1016/j.rdc.2026.02.012}
}
Kostenlos starten →